【康至德】將前沿研究成果轉化為腦退化症的風險預測、診斷和疾病監測工具，利用血液在症狀出現階段之前檢測出認知障礙症。
At Cognitact, we are translating cutting-edge research efforts into a risk prediction, diagnostic and disease monitoring tool for dementia, aiming to detect Alzheimer's disease before its symptomatic stage using blood.
Company Details
- Employees
- 9
- Founded
- -
- Address
- Office 208, 2/f, Building 17w, Hong Kong Science Park, Shatin, N.t., Hong Kong,china,hong Kong
- Industry
- Health And Human Services
- NAICS
-
Administration of Human Resource ProgramsAdministration of Veterans' Affairs
- Website
- http://cognitact.com
- Keywords
- biotech, 生物科技, biomedical, 生物醫療.
- HQ
- Hong Kong, China
Cognitact Limited Questions
Cognitact Limited's website is http://cognitact.com
Cognitact Limited's LinkedIn profile is https://hk.linkedin.com/company/cognitact
Cognitact Limited has
9 employees.
View email and phone details for 9
employees at Cognitact Limited.
Cognitact Limited's industry is
Health and Human Services
Cognitact Limited's top competitors are
Insilico Medicine,
Canthevac Limited,
Ausmed Global,
Astrazeneca,
Hkcend - Hong Kong Center For Neurodegenerative Diseases (香港神經退行性疾病中心),
G-Niib Geniebiome 精進微生物科技有限公司,
Novartis,
Hkstp - Hong Kong Science And Technology Parks Corporation,
Womenx Biotech Limited,
Cognitect.
Cognitact Limited's categories are Health and Human Services
Cognitact Limited's founding year is 2020
